Literature DB >> 18574247

Three consecutive arginines are important for the mycobacterial peptide deformylase enzyme activity.

Rahul Saxena1, Pavitra Kanudia, Manish Datt, Haider Hussain Dar, Subramanian Karthikeyan, Balvinder Singh, Pradip K Chakraborti.   

Abstract

Genes encoding the peptide deformylase enzyme (def) are present in all eubacteria and are involved in the deformylation of the N-formyl group of newly synthesized polypeptides during protein synthesis. We compared the amino acid sequences of this enzyme in different mycobacterial species and found that they are highly conserved (76% homology with 62% identity); however, when this comparison was extended to other eubacterial homologs, it emerged that the mycobacterial proteins have an insertion region containing three consecutive arginine residues (residues 77-79 in Mycobacterium tuberculosis peptide deformylase (mPDF)). Here, we demonstrate that these three arginines are important for the activity of mPDF. Circular dichroism studies of wild-type mPDF and of mPDF containing individual conservative substitutions (R77K, R78K, or R79K) or combined substitutions incorporated into a triple mutant (R77K/R78K/R79K) indicate that such mutations cause mPDF to undergo structural alterations. Molecular modeling of mPDF suggests that the three arginines are distal to the active site. Molecular dynamics simulations of wild-type and mutant mPDF structures indicate that the arginines may be involved in the stabilization of substrate binding pocket residues for their proper interaction with peptide(s). Treatment with 5'-phosphothiorate-modified antisense oligodeoxyribonucleotides directed against different regions of def from M. tuberculosis inhibits growth of Mycobacterium smegmatis in culture. Taken together, these results hold out the possibility of future design of novel mycobacteria-specific PDF inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574247      PMCID: PMC3259783          DOI: 10.1074/jbc.M709672200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents.

Authors:  C Giglione; M Pierre; T Meinnel
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

2.  Structure analysis of peptide deformylases from Streptococcus pneumoniae, Staphylococcus aureus, Thermotoga maritima and Pseudomonas aeruginosa: snapshots of the oxygen sensitivity of peptide deformylase.

Authors:  Andreas Kreusch; Glen Spraggon; Chris C Lee; Heath Klock; Daniel McMullan; Ken Ng; Tanya Shin; Juli Vincent; Ian Warner; Christer Ericson; Scott A Lesley
Journal:  J Mol Biol       Date:  2003-07-04       Impact factor: 5.469

3.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

Review 4.  Challenges in tuberculosis drug research and development.

Authors:  Ann M Ginsberg; Melvin Spigelman
Journal:  Nat Med       Date:  2007-03       Impact factor: 53.440

5.  Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication.

Authors:  G Harth; P C Zamecnik; J Y Tang; D Tabatadze; M A Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene.

Authors:  P S Margolis; C J Hackbarth; D C Young; W Wang; D Chen; Z Yuan; R White; J Trias
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

7.  B-subunit of phosphate-specific transporter from Mycobacterium tuberculosis is a thermostable ATPase.

Authors:  J Sarin; S Aggarwal; R Chaba; G C Varshney; P K Chakraborti
Journal:  J Biol Chem       Date:  2001-09-20       Impact factor: 5.157

8.  Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology.

Authors:  Günter Harth; Marcus A Horwitz; David Tabatadze; Paul C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

9.  Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.

Authors:  Kathrine J Smith; Chantal M Petit; Kelly Aubart; Martin Smyth; Edward McManus; Jo Jones; Andrew Fosberry; Ceri Lewis; Michael Lonetto; Siegfried B Christensen
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

10.  Characterization of a human peptide deformylase: implications for antibacterial drug design.

Authors:  Kiet T Nguyen; Xubo Hu; Craig Colton; Ratna Chakrabarti; Michael X Zhu; Dehua Pei
Journal:  Biochemistry       Date:  2003-08-26       Impact factor: 3.162

View more
  3 in total

1.  High tolerance to mutations in a Chlamydia trachomatis peptide deformylase loop.

Authors:  Christopher B Oey; Xiaofeng Bao; Christal Lewis; John E Kerrigan; Huizhou Fan
Journal:  World J Biol Chem       Date:  2011-05-26

2.  Identification of crucial amino acids of bacterial Peptide deformylases affecting enzymatic activity in response to oxidative stress.

Authors:  Sanjay Kumar; Pavitra Kanudia; Subramanian Karthikeyan; Pradip K Chakraborti
Journal:  J Bacteriol       Date:  2013-10-18       Impact factor: 3.490

3.  Amino-terminal extension present in the methionine aminopeptidase type 1c of Mycobacterium tuberculosis is indispensible for its activity.

Authors:  Pavitra Kanudia; Monica Mittal; Sangaralingam Kumaran; Pradip K Chakraborti
Journal:  BMC Biochem       Date:  2011-07-05       Impact factor: 4.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.